MedTrace Logo

Do Technology Apps Improve Compliance in Adolescent Renal Transplant Recipients?

NCT02610946 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2015-11-20

No results posted yet for this study

Summary

The purpose of this study is to empower adolescent renal transplant recipients to fully understand their medical condition as well as to help them acquire the skills to maintain a healthy allograft well into adulthood. It is hoped that introducing technological applications (apps) will assist adolescents in managing medications, clinic appointments, lab appointments, and in tracking fluid intake, blood pressure, caloric intake, and exercise frequency. The investigators aim to improve adolescent post-renal transplant outcomes (increase medication adherence, lower clinic and laboratory no-show rate, lower blood pressure and BMI, maintain creatinine clearance, decrease proteinuria, decrease incidence of allograft rejection, decrease hospitalizations) as well as reduce cost.

Conditions

  • Kidney Transplantation

Interventions

BEHAVIORAL

Electronic application

Electronic application (app) based intervention to improve adolescent compliance with transplant care and readiness to transition to adult care.

BEHAVIORAL

Paper-based

Paper-based intervention to improve adolescent compliance with transplant care and readiness to transition to adult care.

Sponsors & Collaborators

Principal Investigators

  • Ha Tran, MD · Stanford University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2016-04-30
Completion
2016-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02610946 on ClinicalTrials.gov